Dr. Sanjeev K. Gulati, MD

Dr. Gulati practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Gulati's NPI, 1578574638, was assigned on August 11, 2006. Dr. Gulati holds North Carolina license 200200698.

Dr. Gulati's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Gulati's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Gulati is also affiliated with Lee Memorial Hospital. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Gulati to 9 more medical groups and 8 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gulati practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gulati's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gulati is licensed in North Carolina.

CMS data shows 60 Medicare services from Dr. Gulati across 3 procedure codes in 2024, for 58 Medicare patients. Medicare paid $4,550 for them.

CMS counts 58 Medicare patients who saw Dr. Gulati in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have heart failure, and 75% have high blood pressure. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gulati's median patient age at 68, with 33% women.

In 2024, Dr. Gulati wrote 373 Medicare Part D claims for 72 patients. 69% of them were for generic drugs. CMS names the drug for 267 of them, across 12 drugs with 11 or more claims each, at $98,649 in total drug cost. In 2023, CMS named 183 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gulati for performance year 2024, reported through an alternative payment model (APM). Dr. Gulati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Gulati, published from 2013 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, India and Immunosuppressive Agents. Dr. Gulati has published most often in Indian J Nephrol. Dr. Gulati's most frequent co-authors are Ashish K. Sharma, MD, Manisha Sahay, MD and Keith David Aaronson, MD.

Dmand AI links Dr. Gulati to 7 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Failure, Heart Diseases and Glomerulonephritis, IGA. Abbott Medical Devices sponsors the most, 3.

CMS Open Payments shows 946 general payments to Dr. Gulati from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Novartis Pharmaceuticals Corporation paid the most, $279,987. It also lists 4 research payments totaling $2,250 from 2016 to 2017.